U.S. Oil and Gas Stock News

Recent share performance puts Magnolia Oil & Gas (MGY) in focus Recent moves in Magnolia Oil & Gas (MGY) share price are drawing attention, with the stock up about 24% over the past year but down around 4% over the past month and 6% in the past 3 months. See our latest analysis for Magnolia Oil & Gas. With the share price at $27.51, Magnolia Oil & Gas has pulled back over the past quarter, with a 90 day share price return showing a 5.85% decline, even as its 1 year total shareholder return of...

In late May 2026, The J. M. Smucker Company took part in the Gartner Finance Symposium/Xpo, where Lead Independent Director Jonathan E. Johnson presented insights on the company’s financial and governance priorities at National Harbor, Maryland. At the same time, research highlighting rising input costs and potential earnings pressure for packaged food producers has sharpened investor focus on Smucker’s cost management and margin resilience. We’ll now examine how concerns about rising input...

Axsome Therapeutics recently resolved all U.S. patent litigation over its wake-promoting drug SUNOSI, entering settlements that allow five generic manufacturers to launch versions no earlier than March 1, 2040 (or September 1, 2040 with pediatric exclusivity), subject to regulatory approvals and customary conditions. This long-dated patent clarity for SUNOSI, combined with fresh Phase 3 data and upcoming conference highlights for SYMBRAVO, materially clarifies Axsome’s product durability and...

Why Wendy's Stock Is Drawing Attention Now Wendy's (WEN) is back on many watchlists after a choppy period for the stock, with recent returns mixed across different time frames and investors reassessing what the current valuation implies. See our latest analysis for Wendy's. At a share price of US$6.71, Wendy's has seen its short term momentum weaken, with the 7 day share price return down 12.86% and the year to date share price return down 17.87%. The 1 year total shareholder return is down...

Arrowhead Pharmaceuticals (ARWR) is back in focus after new clinical and regulatory updates around its siRNA platform, including fresh data for plozasiran and ARO-INHBE that were shared at recent European medical meetings. See our latest analysis for Arrowhead Pharmaceuticals. Despite the clinical momentum around plozasiran and ARO-INHBE, short term trading has cooled, with the 7 day share price return down 6.2% and the 30 day share price return down 7.6%, even as the 1 year total shareholder...

MaxLinear (MXL) is back in focus after announcing a collaboration with Los Alamos National Laboratory to bring hardware accelerated OpenZFS storage to large scale high performance computing environments, spotlighting its role in connectivity and storage silicon. See our latest analysis for MaxLinear. The stock has been volatile in recent days, with the share price falling around 14% in the latest session and roughly 13% over the past week. Despite this, it has still posted a very large 1 year...

Recent performance and context for Tenet Healthcare stock Tenet Healthcare (THC) has drawn fresh attention after a mixed stretch for the stock, with recent share performance contrasting with longer term returns and prompting investors to reassess how the business fundamentals line up with current pricing. See our latest analysis for Tenet Healthcare. Recent trading has been choppy, with the share price down 16.68% on a 30 day basis and 31.61% over 90 days. However, the 3 year total...

Custom Truck One Source (CTOS) is back on investors’ radar after two key developments: a cooperative purchasing contract award from Sourcewell and stronger than expected quarterly results paired with a raised full year outlook. See our latest analysis for Custom Truck One Source. Despite the recent 1-day share price return slipping 3.2% to close at US$9.68, Custom Truck One Source has built strong momentum, with a 90-day share price return of 51.01% and a 1-year total shareholder return of...

Recent upward revisions to full year earnings estimates and a higher analyst rating have put fresh attention on Gorman-Rupp (GRC), prompting investors to reassess what the current share price already reflects. See our latest analysis for Gorman-Rupp. At a share price of $77.09, Gorman-Rupp has seen short term share price gains cool slightly over the past month. However, its 90 day share price return of 26.48% and 1 year total shareholder return of 110.08% suggest momentum has been strong over...

Satellogic (SATL) has drawn fresh attention after appointing retired U.S. Army Lieutenant General Michael E. Williamson to its Board as an independent director, highlighting the company’s focus on defense oriented Earth observation services. See our latest analysis for Satellogic. The recent appointment, the more than $18 million defense contract, and investor outreach around the Merlin constellation come as Satellogic’s share price shows mixed momentum, with a sharp 1 day decline but a very...

Archrock (AROC) is back in focus after first quarter 2026 results came in below earnings and revenue estimates, with flat adjusted earnings year over year and guidance for full year adjusted EBITDA reaffirmed. See our latest analysis for Archrock. At a share price of $34.20, Archrock has seen its short term momentum cool, with the 30 day share price return down 12.53% after a softer earnings print. However, the year to date share price return of 28.43% and a very large 5 year total...

Essential Properties Realty Trust, Inc. recently declared a higher quarterly cash dividend of US$0.32 per share for second-quarter 2026, lifting its annualized payout to US$1.28 and continuing a pattern of dividend growth. This increase, backed by a 99.7% leased net-lease portfolio, conservative leverage, and substantial liquidity, underlines management’s confidence in the REIT’s recurring cash flows. Next, we’ll examine how the dividend increase, alongside strong portfolio occupancy, shapes...

Recent Stock Performance Snapshot Walmart (WMT) has drawn investor attention after a mixed stretch in its recent returns, with the stock up over the past year but down over the past month and over the past three months. See our latest analysis for Walmart. For context, Walmart’s recent pullback, with a 30 day share price return of down 8.61% and 90 day share price return of down 3.97%, contrasts with a stronger backdrop that includes a 1 year total shareholder return of 22.98% and a 3 year...

White Mountains Insurance Group recently released its 2026 Annual Investor Presentation, outlining past 2025 results, strong book value per share growth, and key portfolio moves such as the Bamboo sale and HG Global refinancing. A distinctive takeaway is the combination of record capital deployment, substantial undeployed capital, and no parent financial leverage, underscoring the group’s financial flexibility and capacity to pursue new opportunities. Next, we’ll examine how this record...

Earlier in 2026, Voya Investment Management highlighted Mueller Water Products in its Q1 investor letter after the company reported a strong fiscal first quarter and raised guidance, helped by improved execution and margin expansion from its new brass foundry. Investors also focused on how Mueller’s exposure to municipal and utility spending on aging water infrastructure is supporting resilient demand across its core product lines. Next, we’ll explore how this better-than-expected execution...

Aptiv (APTV) is back in focus after two product announcements tied to higher performance computing. An expanded edge AI collaboration with NVIDIA and new high density RF connectors from Winchester Interconnect are drawing attention to the stock. See our latest analysis for Aptiv. The stock has been volatile around these announcements, with a 20.77% 1 month share price return from a recent rally in edge AI enthusiasm. However, it has seen a 12.54% decline year to date and a mixed total...

Franklin Resources (BEN) is back in focus after reporting preliminary assets under management of US$1.78b at May month end, launching a CLO focused ETF, and nearing resolution of a Western Asset regulatory probe. See our latest analysis for Franklin Resources. Franklin Resources’ recent AUM update, launch of the CLO focused ETF and progress on the Western Asset regulatory probe come as the stock trades at US$31.33, with a 90 day share price return of 19.4% and a 1 year total shareholder...

Earlier this week, Frontdoor reported 6% revenue growth driven mainly by pricing and a larger HVAC upgrade program, while keeping gross margin at about 55% and reaffirming its full-year outlook. Management also projected roughly 1% member count growth in 2026, its first expected organic increase since 2020, while underscoring progress on integrating the 2-10 acquisition and ongoing share repurchases. We’ll now examine how this expected return to membership growth could reshape Frontdoor’s...

In early June 2026, FTI Consulting, Inc. increased its share repurchase authorization by US$370 million to a total of US$2.57 billion and released its 2026 Private Equity Value Creation Index, highlighting how artificial intelligence and mergers and acquisitions are influencing value creation for private equity firms. Together, the larger buyback capacity and research on faster AI-enabled value realization and M&A-led returns underscore FTI Consulting’s confidence in capital deployment and...

Why Solidion's Battery Announcements Matter for Stock Watchers Solidion Technology (STI) has put battery chemistry squarely in focus, with fresh announcements on lithium metal anode protection and extreme climate batteries aimed at space, AI data centers, and demanding terrestrial uses. For investors tracking Solidion stock, these product updates highlight how the company is pitching its technology around three long standing hurdles in advanced lithium batteries, along with temperature...

On June 3, 2026, Alnylam Pharmaceuticals and Inceptive Nucleics announced a collaboration worth up to US$2.00 billion, including US$30 million upfront in cash and equity, to apply generative AI to accelerate RNAi drug discovery within Alnylam’s R&D engine. A distinctive aspect of the agreement is Alnylam’s access to Inceptive’s foundation models and AI talent, including Transformer co-inventor Jakob Uszkoreit, aiming to sharpen siRNA design and boost R&D productivity under the Alnylam 2030...

If you are wondering whether BlackSky Technology's current share price lines up with its underlying worth, this breakdown will help you connect the recent moves in the stock with its valuation. The stock closed at US$34.76, after declining 28.3% over the past week and 14.2% over the past month, yet it is still up 67.0% year to date and 169.5% over the past year, with a 152.6% return over three years and a 56.5% decline over five years. Recent coverage has focused on BlackSky Technology's...

Wondering if International Seaways at around US$81 a share still offers value, or if most of the opportunity is already reflected in the price. The stock has been volatile recently, with a 5.0% gain over the past week, a 5.5% decline over the past month, and very strong returns of 72.5% year to date and 135.1% over the last year. Those moves sit against a longer track record where the 3 year return is 206.2% and the 5 year return is a very large gain. This suggests the stock has already...

If you are wondering whether VSE at around US$180 per share still offers value, or if most of the upside is already priced in, this article breaks down what the current market price might be implying. The stock has eased around 2.5% over the past week and around 13.0% over the past month. It is still up 35.4% over the last year and has delivered very large multi year returns, including around 244.8% over three years and 266.5% over five years. Recent coverage has focused on VSE's role in the...